Acute methamphetamine exposure inhibits cardiac contractile function

Toxicology Letters

Volumn 189, Issue 2, 2009, Pages 152-158

  Turdi, Subat ^a   Schamber, Robbie M ^a,b   Roe, Nathan D ^a   Chew Jr , Herbert G ^b   Culver, Bruce ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^b Western Wyoming Community College   (United States)

Author keywords

Adrenergic response; Cardiomyocyte; Methamphetamine; Myocardium; Protein damage

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CELL PROTEIN; METHAMPHETAMINE; NORADRENALIN; PHOSPHOLAMBAN; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ELECTROSTIMULATION; ENDOPLASMIC RETICULUM; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; ISOLATED HEART; MALE; MECHANICAL STIMULATION; MUSCLE CONTRACTION; MUSCLE STRETCHING; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN DEFECT; RAT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CALCIUM; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; HEART; HEART RATE; HOMEODOMAIN PROTEINS; MALE; METHAMPHETAMINE; MICE; MUSCLE CELLS; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

MURINAE; MUS;

EID: 67649389357     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.05.015     Document Type: Article

References (23)

1. Anglin M.D., Burke C., Perrochet B., Stamper E., and Dawud-Noursi S. History of the methamphetamine problem. J. Psychoactive Drugs 32 (2000) 137-141
2. Brodde O.E., Bruck H., and Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J. Pharmacol. Sci. 100 (2006) 323-337
3. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. 36 (2001) 1-22
4. Derlet R.W., and Horowitz B.Z. Cardiotoxic drugs. Emerg. Med. Clin. N. Am. 13 (1995) 771-791
5. 2+ exchange expression on excitation-contraction coupling in genetically modified mice. Ann. N. Y. Acad. Sci. 1047 (2005) 122-126
6. He S.Y., Matoba R., Fujitani N., Sodesaki K., and Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am. J. Forensic Med. Pathol. 17 (1996) 155-162
7. Imam S.Z., Itzhak Y., Cadet J.L., Islam F., Slikker Jr. W., and Ali S.F. Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice. Brain Res. Mol. Brain Res. 91 (2001) 174-178
8. Islam M.N., Kuroki H., Hongcheng B., Ogura Y., Kawaguchi N., Onishi S., and Wakasugi C. Cardiac lesions and their reversibility after long term administration of methamphetamine. Forensic Sci. Int. 75 (1995) 29-43
9. Iwasa M., Maeno Y., Inoue H., Koyama H., and Matoba R. Induction of apoptotic cell death in rat thymus and spleen after a bolus injection of methamphetamine. Int. J. Legal Med. 109 (1996) 23-28
10. Jacobs L.J. Reversible dilated cardiomyopathy induced by methamphetamine. Clin. Cardiol. 12 (1989) 725-727
11. Karch S.B., Stephens B.G., and Ho C.H. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J. Forensic Sci. 44 (1999) 359-368
12. Maeno Y., Iwasa M., Inoue H., Koyama H., Matoba R., and Nagao M. Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes. Forensic Sci. Int. 113 (2000) 239-243
13. Maruta T., Nihira M., and Tomita Y. Histopathological study on acute poisoning of methamphetamine, morphine or cocaine. Nihon Arukoru Yakubutsu Igakkai Zasshi 32 (1997) 122-138
14. NIDA, 1998. Methamphetamine abuse and addiction. In NIDA Research Report.
15. Office of Applied Studies, 2003. Results from the 2002 National Survey on Drug Use and Health: National Findings. In NSDUH Series H-25. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
16. Ren J., Privratsky J.R., Yang X., Dong F., and Carlson E.C. Metallothionein alleviates glutathione depletion-induced oxidative cardiomyopathy in murine hearts. Crit. Care Med. 36 (2008) 2106-2116
17. Ruffoli R., Soldani P., Pasquali L., Ruggieri S., Paparelli A., and Fornai F. Methamphetamine fails to alter the noradrenergic integrity of the heart. Ann. N. Y. Acad. Sci. 1139 (2008) 337-344
18. Urabe M. Inhibitory mechanism of methamphetamine in the isolated myocardium of bullfrog. Arch. Int. Pharmacodyn. Ther. 257 (1982) 239-254
19. Verma S., Yuen V.G., Badiwala M., Anderson T.J., and McNeill J.H. Working heart function in diabetes is not improved by spironolactone treatment. Can. J. Physiol. Pharmacol. 81 (2003) 493-496
20. Wang Y., Hayashi T., Chang C.F., Chiang Y.H., Tsao L.I., Su T.P., Borlongan C., and Lin S.Z. Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke; A Journal of Cerebral Circulation 32 (2001) 775-782
21. Wijetunga M., Seto T., Lindsay J., and Schatz I. Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?. J. Toxicol. Clin. Toxicol. 41 (2003) 981-986
22. Yeo K.K., Wijetunga M., Ito H., Efird J.T., Tay K., Seto T.B., Alimineti K., Kimata C., and Schatz I.J. The association of methamphetamine use and cardiomyopathy in young patients. Am. J. Med. 120 (2007) 165-171
23. Yu Q., Montes S., Larson D.F., and Watson R.R. Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice. Life Sci. 71 (2002) 953-965